How do you track the cost of compounded peptides per patient?

At the protocol level — so the real cost of sourcing and compounding is matched against what each program bills, and you can see which protocols are actually profitable.

We offer several longevity membership tiers. Should they be tracked separately?

Yes — each tier has a different cost profile once compounding and lab work are factored in. Tracking them individually is the only way to know which ones are worth the price you’re charging.

The regulatory environment for peptides feels like it’s always changing. Can you help with that?

We keep your entity and compliance structuring current as the landscape shifts by state and by year, and flag when a change in the rules should prompt a change in how you’re set up.

We’re growing fast and our books haven’t kept up. Can you help?

That’s one of the most common calls we get from longevity clinics. We rebuild the financial infrastructure to match where the practice is actually headed, not just where it started.

Cash-Pay Medical → Longevity

Accounting for Longevity Clinics.

Peptide and longevity clinics combine two things a generalist CPA rarely sees together: real per-patient compounding costs, and a regulatory environment that shifts by state and year. We track those costs by protocol, report each membership tier separately, and keep your structuring current as the rules evolve.

Book a discovery call See longevity-specific problems

Longevity clinic providers consulting in an exam room

Where this accounting goes wrong

The problems specific to this model.

Compounding costs untracked per protocol

Peptide protocols sourced from compounding pharmacies carry real, often significant per-patient costs that vary by protocol and dose — without tracking COGS at the protocol level, margin on your most popular programs is a guess.

Membership tiers with wildly different cost profiles

A basic labs-and-consult tier and a full concierge longevity program have very different underlying costs. Blended into one membership revenue number, you can’t tell which tier is actually profitable once compounding and lab costs are factored in.

Structuring that hasn’t kept up with a shifting regulatory landscape

Peptide and longevity medicine sits in an evolving, state-dependent regulatory environment. Entity and compliance structuring set up at launch often hasn’t been revisited as the rules — and the practice — have changed.

Rapid growth outrunning the back office

Many longevity clinics grow fast in their first two years. Financial infrastructure built for a single-provider startup often can’t answer basic margin questions once the practice adds providers or locations.

How we help